CD&R, McKesson agree to buy Option Care Health for $32.05 a share
Bitget2026/10/06 12:10CD&R and McKesson agreed to acquire Option Care Health for USD 32.05 per share, valuing the business at about USD 5.8 billion. CD&R will own about 51% at closing; McKesson will invest about USD 1.4 billion for about 49%. The deal implies a roughly 37% premium to Option Care Health’s Oct. 5, 2026 close. Closing is expected in the first half of 2027, subject to shareholder vote and required regulatory clearances. Option Care Health is expected to be delisted from Nasdaq and become privately held once the transaction closes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clayton, Dubilier & Rice LLC published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
- CD&R and McKesson agreed to acquire Option Care Health for USD 32.05 per share, valuing the business at about USD 5.8 billion.
- CD&R will own about 51% at closing; McKesson will invest about USD 1.4 billion for about 49%.
- The deal implies a roughly 37% premium to Option Care Health’s Oct. 5, 2026 close.
- Closing is expected in the first half of 2027, subject to shareholder vote and required regulatory clearances.
- Option Care Health is expected to be delisted from Nasdaq and become privately held once the transaction closes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.

